(Q53816251)

English

Comparison of the growth hormone, IGF-1 and insulin in cerebrospinal fluid and serum between patients with motor neuron disease and healthy controls.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

20 May 2018

http://europepmc.org/abstract/MED/17116217

Comparison of the growth hormone, IGF-1 and insulin in cerebrospinal fluid and serum between patients with motor neuron disease and healthy controls. (English)

1 reference

Europe PubMed Central

20 May 2018

http://europepmc.org/abstract/MED/17116217

cerebrospinal fluid

0 references

motor neuron disease

1 reference

based on heuristic

inferred from title

author name string

E Bilic

1

1 reference

Europe PubMed Central

20 May 2018

http://europepmc.org/abstract/MED/17116217

E Bilic

2

1 reference

Europe PubMed Central

20 May 2018

http://europepmc.org/abstract/MED/17116217

I Rudan

3

1 reference

Europe PubMed Central

20 May 2018

http://europepmc.org/abstract/MED/17116217

V Kusec

4

1 reference

Europe PubMed Central

20 May 2018

http://europepmc.org/abstract/MED/17116217

N Zurak

5

1 reference

Europe PubMed Central

20 May 2018

http://europepmc.org/abstract/MED/17116217

D Delimar

6

1 reference

Europe PubMed Central

20 May 2018

http://europepmc.org/abstract/MED/17116217

M Zagar

7

1 reference

Europe PubMed Central

20 May 2018

http://europepmc.org/abstract/MED/17116217

publication date

1 December 2006

1 reference

Europe PubMed Central

20 May 2018

http://europepmc.org/abstract/MED/17116217

European Journal of Neurology

1 reference

Europe PubMed Central

20 May 2018

http://europepmc.org/abstract/MED/17116217

13

1 reference

Europe PubMed Central

20 May 2018

http://europepmc.org/abstract/MED/17116217

1340-1345

1 reference

Europe PubMed Central

20 May 2018

http://europepmc.org/abstract/MED/17116217

12

1 reference

Europe PubMed Central

20 May 2018

http://europepmc.org/abstract/MED/17116217

Stem-cell therapy for amyotrophic lateral sclerosis.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01503.X

21 January 2018

Growth hormone (GH) and GH-releasing peptide-6 increase brain insulin-like growth factor-I expression and activate intracellular signaling pathways involved in neuroprotection.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01503.X

21 January 2018

Muscle expression of a local Igf-1 isoform protects motor neurons in an ALS mouse model

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01503.X

21 January 2018

Synergy of insulin-like growth factor-1 and exercise in amyotrophic lateral sclerosis.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01503.X

21 January 2018

Gene therapy for ALS delivers

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01503.X

21 January 2018

Wild-Type Nonneuronal Cells Extend Survival of SOD1 Mutant Motor Neurons in ALS Mice

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01503.X

21 January 2018

Reduced reactivation rate in mutant CuZnSOD and progression rate of amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01503.X

21 January 2018

El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01503.X

21 January 2018

Cellular pattern of type-I insulin-like growth factor receptor gene expression during maturation of the rat brain: comparison with insulin-like growth factors I and II.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01503.X

21 January 2018

Cerebrospinal fluid insulin-like growth factor-1, insulin growth factor binding protein-2 or nitric oxide are not increased in MS or ALS.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01503.X

21 January 2018

Uptake of circulating insulin-like growth factors (IGFs) into cerebrospinal fluid appears to be independent of the IGF receptors as well as IGF-binding proteins.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01503.X

21 January 2018

Brain neurons develop in a serum and glial free environment: effects of transferrin, insulin, insulin-like growth factor-I and thyroid hormone on neuronal survival, growth and differentiation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01503.X

21 January 2018

Differential effects of insulin on choline acetyltransferase and glutamic acid decarboxylase activities in neuron-rich striatal cultures.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01503.X

21 January 2018

Functions of brain-derived neurotrophic factor, insulin-like growth factor-I and basic fibroblast growth factor in the development and maintenance of dopaminergic neurons

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01503.X

21 January 2018

Ablation of insulin-producing neurons in flies: growth and diabetic phenotypes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01503.X

21 January 2018

Functional properties of the subtype of insulin receptor found on neurons

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01503.X

21 January 2018

IGF-I prevents glutamate-induced motor neuron programmed cell death.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01503.X

21 January 2018

Insulin: new roles for an ancient hormone

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01503.X

21 January 2018

Insulin receptors and insulin action in the brain: review and clinical implications

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01503.X

21 January 2018

Insulin and neurodegenerative disease: shared and specific mechanisms

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01503.X

21 January 2018

Insulin resistance in amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01503.X

21 January 2018

Blood-brain barrier for human growth hormone and insulin-like growth factor-I.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01503.X

21 January 2018

Extracellular space structure revealed by diffusion analysis.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01503.X

21 January 2018

Principal component analysis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2006.01503.X

21 January 2018

Identifiers

10.1111/J.1468-1331.2006.01503.X

1 reference

Europe PubMed Central

20 May 2018

http://europepmc.org/abstract/MED/17116217

1 reference

Europe PubMed Central

20 May 2018

http://europepmc.org/abstract/MED/17116217

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53816251&oldid=1508001157"